Loretta Chin

Loretta's public data

Thumbnail
Toll-like receptor-4 antagonist (+)-naloxone elicits sexually dimorphic attenuation of inflammation-induced fetal programming in mice. Supplemental Tables 1-5
Loretta Chin
2019-06-21T01:42:17Z
Thumbnail
Toll-like receptor-4 antagonist (+)-naloxone elicits sexually dimorphic attenuation of inflammation-induced fetal programming in mice. Supplemental Figure 1
Loretta Chin
2019-06-20T06:28:57Z
Thumbnail
Effect of Toll-like receptor-4 antagonist (+)-naloxone and LPS challenge on gestation length, litter size and early post-natal survival and growth.
Loretta Chin
2018-10-30T04:16:28Z
Thumbnail
Toll-like receptor-4 antagonist (+)-naloxone attenuates fetal programming of offspring growth and adiposity in mice: Supplemental Tables S1-S3
Loretta Chin
2018-10-30T04:04:41Z